Metabolic syndrome

Fatty Acid- and Cholesterol Transporter Protein Expression along the Human Intestinal Tract

“…MS is a clustering of metabolic risk markers, including abdominal obesity, elevated plasma glucose levels, and an atherogenic lipid profile, which altogether contribute to the development of cardiovascular disease (CVD) [3,4]. Patients suffering from the MS often show disturbances in fatty acid (FA) metabolism [5] leading to elevated plasma free fatty acid levels which negatively influence insulinmediated glucose uptake [6,7].…”

Mentha piperita effects on wistar rats plasma lipids

“…High levels of total cholesterol, LDL-c (low density lipoprotein cholesterol) and triacylglycerol associated with lower HDL-c levels can also induce insulin resistance and higher risks of cardiovascular diseases (Willa and Quinones, 2003;Yki-Järvinen, 2003). The combination of all these factors can trigger the Metabolic Syndrome (Lorenzo et al, 2006;Gogia and Agarwal, 2006). Endothelial dysfunction and cardiovascular diseases can be prevented by controlling plasma lipids (Vakkilainen et al, 2000).…”

Metabolic comorbidity in schizophrenia

“…[38] [39] A recent prospective study done in India in previously drug-naïve patients with schizophrenia revealed an increased incidence of metabolic syndrome, of 31.81% cases, after 6 weeks of therapy with a single antipsychotic drug in comparison of an incidence of 3.33% at baseline. [29] Routine screening for these conditions does not happen as regularly, especially in large psychiatric units and hospitals.…”